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impact of HT and cM1 (p=0.018 with HR =0.593 and p=0.006 
with HR=2.574, respectively). In the multivariate analysis of 
LPFS, HT and 2 RT-FLASH had prognostic impact (p=0.039 
with HR=0.297 and p=0.036 with HR=0.257, respectively). 
 
Conclusion: In the context of LABC, with poor prognosis, RT-
FLASH improves the quality of life, without registration of 
acute toxicity, and with reasonable OS. HT and the absence 
of metastasis at diagnosis had a positive impact on prognosis, 
significantly. LPFS was significantly higher in patients who 
underwent two RT-FLASH or HT. 
 
EP-1198  
Evaluation of pulmonary acute/ subacute toxicity after 
different techniques of breast radiotherapy 
B. Serarslan
1Istanbul University- Faculty of Medicine, Department of 
Radiation Oncology, Istanbul, Turkey 
1, Y. Sanlı2, M. Fayda1, C. Türkmen1, M. Erelel3, N. 
Dönmez Kesen4, N.S. Küçücük1 
2Istanbul University- Faculty of Medicine, Department of 
Nuclear Medicine, Istanbul, Turkey 
3Istanbul University- Faculty of Medicine, Department of 
Pulmonary Medicine, Istanbul, Turkey 
4Istanbul University, Department of Medical Physics, 
Istanbul, Turkey 
 
Purpose or Objective: The increase in the local control and 
survival of breast cancer patients with postoperative 
radiotherapy(RT) has been demonstrated by many of 
randomized trials and metaanalysis. Because of this longer 
life expectancy; quality of life and minimizing of treatment 
toxicity have gained importance. More homogenous dose 
distribution in the treatment field and reduction of side 
effects is possible with new RT techniques. The aims of our 
study are to evaluate acute/subacute pulmonary effects and 
their differences with different RT modalities of 
postoperative breast RT via pulmonary function tests (PFT) 
and single photon emission computer tomography (SPECT) 
based lung perfusion scintigraphy (SLPS), and to exhibit 
optimum lung dose constraints data for breast cancer RT. 
Additionally this study enables to detect early pulmonary 
toxicity in the asymptomatic period and to treat it, if 
necessary. 
 
Material and Methods: In our study, voluntary breast cancer 
patients eligible for postoperative RT, who completed 
adjuvant systemic chemotherapy were separated equally into 
two groups of different RT techniques [3D conformal RT (3D-
CRT) and intensity-modulated radiotherapy (IMRT)]. To assess 
the acute/subacute pulmonary toxicity, we performed PFT 
and SLPS just before RT (baseline) and after 3 months of RT 
(control). After 1 month of RT patients were rechecked with 
only PFT. We assessed the relation between dosimetric data 




Figure 1: Fusion of single photon emission computer 
tomography (SPECT) based lung perfusion scintigraphy (SLPS) 
images and radiotherapy plans via VelocityAI® programme 
 
Results: Mean lung doses and lung volumes receiving ≤20Gy 
(V1, V5, V10, V20) were significantly higher in IMRT group 
(p<0.001) (Figure 2). There was no significant difference in 
PFT changes after RT between the two RT techniques 
(p>0.05). Higher lung doses (p<0.001) and more significant 
mean reduction of scintigraphic uptake were observed in low 
dose volumes with IMRT (p<0.05). In 3D-CRT group, the mean 
reduction of scintigraphic uptake was higher in the lobe, that 
receives the highest mean dose (ipsilateral lobe) (p<0.05). 
Furthermore, even though right supraclavicular area, which 
effects the upper lung zone was irradiated, frequently the 
right middle lobe received more radiation, not right upper 
lobe. Eventually, none of the patients had grade ≥2 LENT -
SOMA lung toxicity. We didn’t find any relationship between 
patient characteristics (smoking history, age, chemotherapy 
type, surgery type, tumor location, RT field and technique) 
and radiation induced pulmonary toxicity. 
   
 
 
Figure 2: Bilateral lung, ipsilateral lung ve ipsilateral lung 
lobe mean V1, V5, V10, V20, V30, V40, V50 values 
 
Conclusion: We found that V20 volume of lung is a similar 
parameter for evaluation of different breast RT techniques 
and evaluation of low and high dose volumes can be more 
feasible. Larger group of patients and longer follow-up can 
lead to more significant results.  
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Purpose or Objective: Cardiac dose delivered during 
tangential radiotherapy is increasingly scrutinized, but the 
cardiac dose delivered during electron boost is not routinely 
calculated. We retrospectively reviewed cases in which an 
electron boost was employed to deliver a phase 2 to a tumour 
bed (TB) overlying the heart to establish the proportion of 
cases and type of cases in which this treatment delivered a 
significant cardiac dose.  
 
Material and Methods: A cohort of left sided breast cancer 
cases receiving radiotherapy in a single treatment centre 
over a 4 month period were reviewed. Those patients 
receiving a phase 2 electron boost to a TB in the mid/ lower 
part of the left breast were identified. For those in which an 
electron beam was incident on the heart, fully commissioned 
Monte Carlo dose calculation was used to derive the dose 
delivered to whole heart and left anterior descending artery 
assuming a boost dose of 16Gy in 8 fractions to the 100%. 
 
Results: A total of 24 patients received a boost to a TB in the 
mid/ lower part of the left breast. Of these, 15 were treated 
with an electron beam incident on the heart. In 6/15 (40%) 
the mean heart dose delivered by the boost component was 
0.5Gy. The maximum mean heart dose was 1.02Gy. In all 6 
cases, the energy employed was >9MeV. 
 
Conclusion: The heart dose delivered by an electron boost 
with beam incident on the heart can be significant, especially 
if an energy >9MeV is employed. In such cases, mini-
tangential treatment in deep inspiratory breath hold is 
recommended. 
